These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1533985)

  • 1. Interleukin-2-induced cytotoxicity of Chediak-Higashi lymphocytes.
    Holcombe RF
    Acta Haematol; 1992; 87(1-2):45-8. PubMed ID: 1533985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-delta T cells in Chediak-Higashi syndrome.
    Holcombe RF; van de Griend R; Ang SL; Bolhuis RL; Seidman JG
    Acta Haematol; 1990; 83(4):193-7. PubMed ID: 2115716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
    Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
    J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome.
    Nakazawa T; Agematsu K; Yasui K; Onodera T; Inoue R; Kaneko H; Kondo N; Yamamoto M; Kayagaki N; Yagita H; Okumura K; Komiyama A
    Clin Exp Immunol; 1999 Oct; 118(1):108-14. PubMed ID: 10540167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2.
    Cifaldi L; Pinto RM; Rana I; Caniglia M; Angioni A; Petrocchi S; Cancrini C; Cursi L; Palumbo G; Zingoni A; Gismondi A; Rossi P; Santoni A; Cerboni C
    Immunol Lett; 2016 Dec; 180():46-53. PubMed ID: 27816481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.
    Katz P; Zaytoun AM; Fauci AS
    J Clin Invest; 1982 Jun; 69(6):1231-8. PubMed ID: 6177715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
    Brahmi Z
    Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
    Gravekamp C; Vreugdenhil R; Bolhuis RL
    FEMS Microbiol Immunol; 1988 Jan; 1(1):31-9. PubMed ID: 2978812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
    Wang J; Liu Z; Jiang LP; An YF; Zhao XD
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
    Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
    J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells.
    Bensussan A; Lagabrielle JF; Castaigne S; Boisson N; Miclea JM; Benbunan M; Degos L
    Nouv Rev Fr Hematol (1978); 1989; 31(2):129-32. PubMed ID: 2528119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic and functional characterization of human peripheral blood T cells expressing the T cell receptor gamma/delta.
    Ferrini S; Zarcone D; Viale M; Cerruti G; Millo R; Moretta A; Grossi CE
    Eur J Immunol; 1989 Jul; 19(7):1183-8. PubMed ID: 2527156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
    De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
    Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes.
    Faure F; Jitsukawa S; Triebel F; Hercend T
    J Immunol; 1988 Mar; 140(5):1372-9. PubMed ID: 2964471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of deficient natural killer activity and delayed bactericidal activity by a thiol proteinase inhibitor, E-64-d, in leukocytes from Chediak-Higashi syndrome patients in vitro.
    Tanabe F; Kasai H; He L; Kin T; Fujikado T; Kumamoto T; Hara T; Iwata T; Ito M
    Int Immunopharmacol; 2009 Mar; 9(3):366-70. PubMed ID: 19185618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.